- Home
- APYX vs SRZN Comparison
APYX vs SRZN Comparison
Compare APYX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- SRZN
- Stock Information
- Founded
- APYX 1982
- SRZN 2015
- Country
- APYX United States
- SRZN United States
- Employees
- APYX N/A
- SRZN N/A
- Industry
- APYX Medical/Dental Instruments
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- APYX Health Care
- SRZN Health Care
- Exchange
- APYX Nasdaq
- SRZN Nasdaq
- Market Cap
- APYX 84.7M
- SRZN 72.8M
- IPO Year
- APYX 1987
- SRZN N/A
- Fundamental
- Price
- APYX $2.15
- SRZN $8.71
- Analyst Decision
- APYX Hold
- SRZN Strong Buy
- Analyst Count
- APYX 2
- SRZN 2
- Target Price
- APYX N/A
- SRZN $38.50
- AVG Volume (30 Days)
- APYX 96.0K
- SRZN 22.6K
- Earning Date
- APYX 08-07-2025
- SRZN 08-11-2025
- Dividend Yield
- APYX N/A
- SRZN N/A
- EPS Growth
- APYX N/A
- SRZN N/A
- EPS
- APYX N/A
- SRZN N/A
- Revenue
- APYX $47,288,000.00
- SRZN $11,638,000.00
- Revenue This Year
- APYX $2.25
- SRZN N/A
- Revenue Next Year
- APYX $6.76
- SRZN N/A
- P/E Ratio
- APYX N/A
- SRZN N/A
- Revenue Growth
- APYX N/A
- SRZN N/A
- 52 Week Low
- APYX $0.76
- SRZN $5.90
- 52 Week High
- APYX $2.73
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- APYX 54.50
- SRZN 47.45
- Support Level
- APYX $2.12
- SRZN $8.00
- Resistance Level
- APYX $2.73
- SRZN $8.94
- Average True Range (ATR)
- APYX 0.26
- SRZN 0.72
- MACD
- APYX -0.00
- SRZN -0.07
- Stochastic Oscillator
- APYX 40.63
- SRZN 27.14
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).